Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,175.10 | 49.90 | 0.61% |
CAC 40 | 7,532.96 | 30.18 | 0.40% |
DAX 40 | 22,098.15 | 33.64 | 0.15% |
Dow JONES (US) | 40,093.40 | 486.83 | 1.23% |
FTSE 100 | 8,405.10 | 2.34 | -0.03% |
HKSE | 21,976.84 | 67.08 | 0.31% |
NASDAQ | 17,166.04 | 457.99 | 2.74% |
Nikkei 225 | 35,705.74 | 666.59 | 1.90% |
NZX 50 Index | 12,017.84 | 61.37 | 0.51% |
S&P 500 | 5,484.77 | 108.91 | 2.03% |
S&P/ASX 200 | 7,968.20 | 47.70 | 0.60% |
SSE Composite Index | 3,295.06 | 2.23 | -0.07% |